Document is current
Any future updates will be listed below
-
Authors
Kaiser, Yannik
Garris, Christopher S. https://orcid.org/0000-0002-5764-6203
Marinari, Eliana
Kim, Hyung Shik
Oh, Juhyun
Pedard, Martin
Halabi, Elias A.
Choi, Moonhyun
Parvanian, Sepideh
Kohler, Rainer https://orcid.org/0000-0001-6269-6590
Migliorini, Denis https://orcid.org/0000-0003-0151-3222
Weissleder, Ralph https://orcid.org/0000-0003-0828-4143
-
Funding
Funding for this research was provided by:
Deutscher Akademischer Austauschdienst (German Academic Exchange Service)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA281735, R33CA277820, R33CA277820, R33CA277820, R33CA277820, R33CA277820, R01CA281735, R01CA281735)
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 3 September 2025
First Online: 22 October 2025
Competing interests
: R.W. is a consultant for Boston Scientific, Earli and Accure Health, none of whom contributed to or were involved in this research. R.W. is an inventor on multiple patents, all managed institutionally through Massachusetts General Brigham. D.M. is a consultant for Limula and MPC Therapeutics, scientific co-founder of Cellula Therapeutics and is an inventor on patents related to CAR–T cell therapy filed by the University of Pennsylvania, Istituto Oncologico della Svizzera Italiana (IOSI) and the University of Geneva. The remaining authors declare no competing interests.
